Lynn Kamen

614 total citations
22 papers, 451 citations indexed

About

Lynn Kamen is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Lynn Kamen has authored 22 papers receiving a total of 451 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology, 9 papers in Radiology, Nuclear Medicine and Imaging and 8 papers in Molecular Biology. Recurrent topics in Lynn Kamen's work include Monoclonal and Polyclonal Antibodies Research (9 papers), CAR-T cell therapy research (7 papers) and Biosimilars and Bioanalytical Methods (5 papers). Lynn Kamen is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (9 papers), CAR-T cell therapy research (7 papers) and Biosimilars and Bioanalytical Methods (5 papers). Lynn Kamen collaborates with scholars based in United States, Switzerland and France. Lynn Kamen's co-authors include Joel A. Swanson, Jonathan Levinsohn, Clifford A. Lowell, Joseph Schlessinger, Philip D. King, Shan Chung, Jörn Drappa, Uma Sinha, Dalit Ashany and Susheela Tridandapani and has published in prestigious journals such as Nature Communications, The Journal of Experimental Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Lynn Kamen

20 papers receiving 442 citations

Peers

Lynn Kamen
Szilvia Lukácsi Hungary
Ken Ito United States
Catarina Sacristán United States
Le Sun China
Cynthia Detre United States
Carl‐Magnus Högerkorp Sweden
Robert R. Getty United States
Aleksandra Gil‐Krzewska United States
Yukai Jing China
Cristina Capuano Italy
Szilvia Lukácsi Hungary
Lynn Kamen
Citations per year, relative to Lynn Kamen Lynn Kamen (= 1×) peers Szilvia Lukácsi

Countries citing papers authored by Lynn Kamen

Since Specialization
Citations

This map shows the geographic impact of Lynn Kamen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lynn Kamen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lynn Kamen more than expected).

Fields of papers citing papers by Lynn Kamen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lynn Kamen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lynn Kamen. The network helps show where Lynn Kamen may publish in the future.

Co-authorship network of co-authors of Lynn Kamen

This figure shows the co-authorship network connecting the top 25 collaborators of Lynn Kamen. A scholar is included among the top collaborators of Lynn Kamen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lynn Kamen. Lynn Kamen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ruppel, Jane, et al.. (2025). Atezolizumab neutralizing assay development: a novel way of evaluating assay cutpoint after sample pretreatment. SHILAP Revista de lepidopterología. 11(1).
2.
Partridge, Michael A., Lynn Kamen, Bonnie Wu, et al.. (2025). Assessment of Neutralizing Antibody Activity in Clinical Studies: Use of Surrogate Measurements Instead of Stand-alone Assays. The AAPS Journal. 27(5). 132–132.
3.
Williams, William T., Kathryn J. Lindley, Hong Liao, et al.. (2024). Development of a validated novel bead extraction method for the detection of anti-PEG antibodies in human serum. Bioanalysis. 17(1). 7–15. 2 indexed citations
4.
Miller, Michelle S., Lynn Kamen, Roman Wernyj, et al.. (2023). Validation of Anti-Adeno Associated Virus Serotype rh10 (AAVrh.10) Total and Neutralizing Antibody Immunogenicity Assays. Pharmaceutical Research. 40(10). 2383–2397. 4 indexed citations
5.
6.
Hammer, Christian, Jane Ruppel, Lynn Kamen, et al.. (2022). Allelic variation in HLA‐DRB1 is associated with development of a ntidrug antibodies in cancer patients treated with atezolizumab that are neutralizing in vitro. Clinical and Translational Science. 15(6). 1393–1399. 8 indexed citations
7.
Tran, Peter, Justin Low, Manda Wong, et al.. (2022). Introducing Dendritic Cell Antibody Internalization as an Immunogenicity Risk Assessment Tool. Bioanalysis. 14(10). 703–713. 10 indexed citations
8.
Kamen, Lynn, et al.. (2021). Method for Measurement of Antibody-Dependent Cellular Phagocytosis. Methods in molecular biology. 2313. 305–312. 3 indexed citations
9.
Huang, Weize, Junyi Li, Michael Z. Liao, et al.. (2021). Clinical Pharmacology Perspectives for Adoptive Cell Therapies in Oncology. Clinical Pharmacology & Therapeutics. 112(5). 968–981. 16 indexed citations
10.
Kamen, Lynn, et al.. (2019). A novel method for determining antibody-dependent cellular phagocytosis. Journal of Immunological Methods. 468. 55–60. 40 indexed citations
11.
Kamen, Lynn, et al.. (2019). Development of a kinetic antibody-dependent cellular cytotoxicity assay. Journal of Immunological Methods. 468. 49–54. 1 indexed citations
12.
Chung, Shan, Yuwen Linda Lin, Nguyễn Văn Hiệp, et al.. (2018). Development of a label-free FcRn-mediated transcytosis assay for in vitro characterization of FcRn interactions with therapeutic antibodies and Fc-fusion proteins. Journal of Immunological Methods. 462. 101–105. 10 indexed citations
13.
Chai, Ning, Lee R. Swem, Summer Park, et al.. (2017). A broadly protective therapeutic antibody against influenza B virus with two mechanisms of action. Nature Communications. 8(1). 14234–14234. 49 indexed citations
14.
Chung, Shan, Nguyễn Văn Hiệp, Yuwen Linda Lin, Lynn Kamen, & An Song. (2017). Thaw-and-use target cells pre-labeled with calcein AM for antibody-dependent cell-mediated cytotoxicity assays. Journal of Immunological Methods. 447. 37–46. 11 indexed citations
15.
Fumagalli, Laura, et al.. (2014). Src Family Kinases and Syk Are Required for Neutrophil Extracellular Trap Formation in Response to β-Glucan Particles. Journal of Innate Immunity. 7(1). 59–73. 43 indexed citations
16.
Coffey, Greg, Francis DeGuzman, Lynn Kamen, et al.. (2012). PRT062070: A Dual Syk/JAK Inhibitor with Potent Immune Regulatory Capacity in Rodent Models of Inflammation and Cancer.. Blood. 120(21). 2764–2764. 4 indexed citations
17.
Kamen, Lynn, Joseph Schlessinger, & Clifford A. Lowell. (2010). Pyk2 Is Required for Neutrophil Degranulation and Host Defense Responses to Bacterial Infection. The Journal of Immunology. 186(3). 1656–1665. 46 indexed citations
18.
Kamen, Lynn, et al.. (2008). SHIP-1 Increases Early Oxidative Burst and Regulates Phagosome Maturation in Macrophages. The Journal of Immunology. 180(11). 7497–7505. 41 indexed citations
19.
Heinsbroek, Sigrid E.M., Lynn Kamen, Philip R. Taylor, et al.. (2008). Actin and Phosphoinositide Recruitment to Fully Formed <i>Candida albicans </i>Phagosomes in Mouse Macrophages. Journal of Innate Immunity. 1(3). 244–253. 22 indexed citations
20.
Kamen, Lynn, Jonathan Levinsohn, & Joel A. Swanson. (2007). Differential Association of Phosphatidylinositol 3-Kinase, SHIP-1, and PTEN with Forming Phagosomes. Molecular Biology of the Cell. 18(7). 2463–2472. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Szilvia Lukácsi Breakdown of academic impact, for papers by Ken Ito Breakdown of academic impact, for papers by Catarina Sacristán Breakdown of academic impact, for papers by Le Sun Breakdown of academic impact, for papers by Cynthia Detre Breakdown of academic impact, for papers by Carl‐Magnus Högerkorp Breakdown of academic impact, for papers by Robert R. Getty Breakdown of academic impact, for papers by Aleksandra Gil‐Krzewska Breakdown of academic impact, for papers by Yukai Jing Breakdown of academic impact, for papers by Cristina Capuano
Rankless by CCL
2026